Back
InMed Pharmaceuticals Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
27
INM
InMed Pharmaceuticals
Last Price:
0.24
Seasonality Move:
23.96%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!InMed Pharmaceuticals Price Quote
$0.24
0.00 (-7.87%)
(Updated: November 5, 2024 at 2:48 AM ET)
InMed Pharmaceuticals Key Stats
Sell
27
InMed Pharmaceuticals (INM)
is a Sell
Day range:
$0.23 - $0.27
52-week range:
$0.12 - $0.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.43
P/B ratio:
0.38%
Volume:
317.6K
Avg. volume:
800.1K
1-year change:
-47.29%
Market cap:
$3.5M
Revenue:
$4.6M
EPS:
$-1.32
How Much Does InMed Pharmaceuticals Make?
-
How Much Are InMed Pharmaceuticals's Sales Annually?
INM Revenues are $4.6M -
How Much Profit Does InMed Pharmaceuticals's Make A Year?
INM net income is -$7.7M
Is InMed Pharmaceuticals Growing As A Company?
-
What Is InMed Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.44% -
What Is InMed Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
InMed Pharmaceuticals Stock Price Performance
-
Did InMed Pharmaceuticals Stock Go Up Last Month?
InMed Pharmaceuticals share price went up by 20.18% last month -
Did INM's Share Price Rise Over The Last Year?
INM share price fell by -47.29% over the past 1 year
What Is InMed Pharmaceuticals 52-Week High & Low?
-
What Is InMed Pharmaceuticals’s 52-Week High Share Price?
InMed Pharmaceuticals has traded as high as $0.78 over the past 52 weeks -
What Is InMed Pharmaceuticals’s 52-Week Low Share Price?
InMed Pharmaceuticals has traded as low as $0.12 over the past 52 weeks
InMed Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy InMed Pharmaceuticals?
-
How Much Debt Does InMed Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does InMed Pharmaceuticals Have?
Cash and short term investments quarterly total is $6.6M -
What Is InMed Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.03
Is InMed Pharmaceuticals Cash Flow Positive?
-
What Is INM Cash Flow From Operations?
Cash flow from operations (TTM) is -$7M -
What Is InMed Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.7M -
What Is InMed Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$9.3K
InMed Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
INM return on invested capital is -70.1% -
What Is InMed Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -58.63% -
What Is INM Return On Equity?
ROE is a measure of profitability and is -70.1%
InMed Pharmaceuticals Earnings Date & Stock Price
-
What Is InMed Pharmaceuticals's Stock Price Today?
A single share of INM can be purchased today for 0.24 -
What Is InMed Pharmaceuticals’s Stock Symbol?
InMed Pharmaceuticals trades on the nasdaq under the ticker symbol: INM -
When Is InMed Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for InMed Pharmaceuticals is scheduled on November 14, 2024 -
When Is INM's next ex-dividend date?
InMed Pharmaceuticals's next ex-dividend date is November 5, 2024 -
How To Buy InMed Pharmaceuticals Stock?
You can buy InMed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
InMed Pharmaceuticals Competitors
-
Who Are InMed Pharmaceuticals's Competitors?
Below is a list of companies who compete with InMed Pharmaceuticals or are related in some way:
InMed Pharmaceuticals Dividend Yield
-
What Is INM Dividend Yield?
InMed Pharmaceuticals’s dividend yield currently is 0% -
What Is InMed Pharmaceuticals’s Payout Ratio?
InMed Pharmaceuticals’s payout ratio is 0% -
When Did InMed Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is InMed Pharmaceuticals’s Dividend Per Share?
InMed Pharmaceuticals pays a dividend of $0.00 per share
InMed Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -44.48% | -21.35% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 20.47 |
| Upside from Last Price: | 8324.28% |